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Following primary ocular infection, herpes simplex virus type 1 (HSV-1) establishes a lifelong latent
infection in sensory neurons of the trigeminal ganglia. Latency-associated transcript (LAT), the only known
viral gene abundantly transcribed during HSV-1 neuronal latency, is required for high levels of reactivation.
Recently we showed that three different mutants that do not alter the LAT promoter but contain deletions
within the 5 end of the primary LAT transcript affect viral virulence (G. C. Perng et al., J. Virol. 75:9018-9028,
2001). In contrast, in LAT-null mutants viral virulence appears unaltered (T. M. Block et al., Virology
192:618-630, 1993; D. C. Bloom et al., J. Virol. 68:1283-1292, 1994; J. M. Hill et al., Virology 174:117-125, 1990;
G. C. Perng et al., J. Virol. 68:8045-8055, 1994; F. Sedarati, K. M. Izumi, E. K. Wagner, and J. G. Stevens,
J. Virol. 63:4455-4458, 1989). We therefore hypothesized that the 5 end of LAT and/or an as yet unidentified
gene that overlaps part of this region is involved in viral virulence. We report here on the discovery and initial
characterization of a novel HSV-1 RNA consistent with such a putative gene. The novel RNA was antisense to
the 5 end of LAT and was designated AL-RNA (anti-LAT sense RNA). The AL-RNA overlapped the core LAT
promoter and the first 158 nucleotides of the 5 end of the primary LAT transcript. AL-RNA was detected in
extracts from neuron-like cells (PC-12) infected with wild-type HSV-1 but not in cells infected with a mutant
with the AL region deleted. The deletions in each of the above three mutants with altered virulence encompass
the 5 end of the AL-RNA, and these mutants cannot transcribe AL. This supports the hypothesis that the AL
gene may play a role in viral virulence. Based on comparison to the corresponding genomic sequence, the
AL-RNA did not appear to be spliced. The AL-RNA was polyadenylated and contained an open reading frame
capable of encoding a protein 56 amino acids in length with a predicted molecular mass of 6.8 kDa. Sera from
three of three rabbits infected with wild-type HSV-1 but not sera from any of three rabbits infected with a
mutant with the AL-RNA region deleted recognized the Escherichia coli recombinantly expressed AL open
reading frame on Western blots. In addition, four of six rabbits infected with wild-type virus developed
enzyme-linked immunosorbent assay titers against one or more AL synthetic peptides. These results suggest
that an AL protein is produced in vivo.
Herpes simplex virus type 1 (HSV-1) is a large (152-kbp)
double-stranded neurotropic DNA virus. The majority of
adults in the United States are HSV-1 seropositive. HSV-1
infects mucosal tissues, usually the mouth, nose, eye, or genital
tract. Following ocular infection, HSV-1 travels up nerves and
establishes latent infection in sensory neurons of the trigeminal
ganglia. Although it is well known that the latent virus can
reactivate at various times throughout the life of an individual
and produce recurrent disease, the mechanism(s) by which this
occurs remains to be fully elucidated. Recurrent ocular HSV-1
infection can produce corneal scarring leading to loss of vision.
As a result, HSV-1 is one of the most common infectious
causes of corneal blindness in the developed world.
Latency-associated transcript (LAT) is the only abundantly
transcribed viral gene during neuronal latency (28, 35). The
primary LAT transcript is 8.3 to 8.5 kb long (9, 43). A very
stable intron, the 2-kb LAT, is spliced from the primary tran-
script (11). This 2-kb LAT intron is the major LAT RNA
detected during latency (9, 32, 34, 38, 39, 42). The LAT gene
is located in the viral long repeats and is thus present in two
identical copies. As such, the LAT region accounts for over 16
kb of the 152-kb HSV-1 genome. Having one gene occupy over
10% of the genome of a virus that contains over 80 genes
suggests that there is high selective pressure to maintain the
sequence of the LAT region. Not surprisingly, there are also
other genes in the LAT region. LAT overlaps the viral genes
for ICP0 and ICP34.5 in an antisense direction (28, 35).
Studies with various LAT mutants have shown that LAT
increases the induced and spontaneous reactivation pheno-
types in the rabbit ocular model (14, 20) and the induced
reactivation phenotype in mice (3, 8, 16, 23, 29, 33). This may
be the result of LAT enhancing establishment of latency, LAT
being directly involved in the reactivation stage, or a combina-
* Corresponding author. Present address: Department of Ophthal-
mology, University of California Irvine, UCI Medical Center, Bldg. 55,
2nd floor, 101 The City Dr., Orange, CA 92868. Phone: (714) 456-5043.
Fax: (714) 456-5073.
† Present address: Department of Ophthalmology, University of
California Irvine, UCI Medical Center, Orange, CA 92868.
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tion of both (19, 25). Support for a role for LAT in the estab-
lishment of latency comes from reports showing that in rabbits
and mice more neurons become latently infected with LAT
virus than with LAT virus (25, 29, 36). In addition, LAT has
antiapoptosis activity (1, 15, 19). This could protect acutely
infected neurons from death and result in increased establish-
ment of latency. It should be noted that these findings do not
rule out an additional role for LAT in the reactivation stage.
Interestingly, a LAT-null mutant containing the LAT pro-
moter driving the first 1.5 kb of LAT from an ectopic location
in the virus (22) and a mutant containing a polyadenylation
signal inserted at LAT nucleotide 1499 (5) both have wild-type
levels of reactivation. Thus, the major LAT function(s) in-
volved in the latency-reactivation cycle appears to reside within
the first 1.5 kb of the primary 8.3- to 8.5-kb transcript.
Although LAT-null mutants (i.e., mutants unable to tran-
scribe any LAT) appear to have virulence properties similar to
their wild-type parents (3, 4, 14, 20, 30), it has been proposed
elsewhere that the 5 end of LAT or a gene in this region of the
HSV-1 genome may affect viral virulence (21, 41). This is
based, at least partially, on the altered viral virulence of some
LAT mutants with deletions in the 5 end of the primary LAT
transcript that do not block transcription of the remainder of
LAT (21, 24). This suggests that there are two functions, one
involved in reactivation and one involved in virulence, that
map to the genomic location corresponding to the 5 end of
LAT (i.e., the first 1.5 kb of LAT discussed above). One or
both of these functions may reside in LAT or in a gene over-
lapping the 5 end of LAT. Several LAT sense transcripts that
terminate just prior to the 5 end of LAT have been reported
previously (31, 41), and one of these transcripts has been pro-
posed previously to be involved in virulence (41). However,
since this transcript does not overlap any of the LAT RNA it
is unlikely to account for the altered virulence seen for mutants
containing deletions only within the LAT RNA (21, 24). Con-
sequently, we searched for other possible non-LAT transcripts
near the start of LAT transcription.
We report here the discovery of a transcript antisense to
LAT (AL-RNA) that overlaps the 5 end of LAT and the core
LAT promoter. AL-RNA was detected by reverse transcrip-
tion-PCR (RT-PCR) in PC-12 cells acutely infected with wild-
type HSV-1 but not in uninfected PC-12 cells or PC-12 cells
infected with the LAT-null mutant dLAT2903 (20) (which also
has the entire AL region deleted). We mapped the 5 and 3
ends of the AL-RNA and found that the transcript is polyad-
enylated and extends from LAT nucleotide 158 to LAT nu-
cleotide 198 (on the other DNA strand). The deletions
within the three LAT mutants with altered viral virulence dis-
cussed above each remove the 5 end of AL and hence result
in AL-null mutants. The findings reported here are therefore
consistent with the notion that AL is involved in viral virulence.
We also found that serum from rabbits infected with wild-type
HSV-1 recognized recombinantly expressed AL protein, sug-
gesting that an AL protein is made in vivo.
MATERIALS AND METHODS
Virus and cells. All parental and mutant viruses were triple plaque purified
and passaged only one or two times in rabbit skin (RS) cells prior to use.
Wild-type McKrae, the McKrae-derived LAT dLAT2903, and marker-rescued
dLAT2903R viruses have been previously described (20). RS cells were grown in
Eagle’s minimal essential medium supplemented with 5% fetal calf serum. PC-12
cells were grown in the same medium supplemented with 10% fetal calf serum
and 5% horse serum.
Rabbits. Eight- to 10-week-old New Zealand White male rabbits (Irish Farms)
were used. Rabbits were treated in accordance with Association for Research in
Vision and Ophthalmology, American Association for Laboratory Animal Care,
and National Institutes of Health guidelines. Rabbits were bilaterally infected
without scarification or anesthesia by placing 2  105 PFU of virus into the
conjunctival cul-de-sac, closing the eye, and rubbing the lid gently against the eye
for 30 s as we previously described (28).
RNA isolation. Subconfluent cell monolayers were infected at a multiplicity of
infection (MOI) of 5 PFU/cell, total RNA was isolated at various times postin-
fection (p.i.), and Northern blot analysis was performed according to standard
protocols with various 32P-labeled oligonucleotide probes specific for the detec-
tion of anti-LAT transcripts in the immediate vicinity of the LAT promoter and
the start of LAT transcription.
RT-PCR. Cells were infected at an MOI of 5 PFU/cell or mock infected.
Poly(A) mRNA was isolated from total cell extracts with the PolyATract mRNA
Isolation System IV (catalogue no. Z5310; Promega, Madison, Wis.), according
to the manufacturer’s directions. RT was done with the ThermoScript RT-PCR
system (catalogue no. 11146-024; Invitrogen Life Technologies, San Diego, Cal-
if.) according to the manufacturer’s directions. The primer used for cDNA
synthesis was either oligo(dT) or an oligonucleotide corresponding to HSV-1
genomic nucleotides 118661 to 118690 (LAT nucleotides 140 to 111; see Fig.
1E, primer a). All PCRs were done with primer a (see previous sentence) and
primer d (corresponding to HSV-1 nucleotides 118910 to 118881 or LAT nucle-
otides 109 to 80; see Fig. 1E, primer d). The PCR was initiated at 90°C for 5 min.
This was followed by 30 cycles of 94°C for 40 s, 60°C for 30 s, and 71°C for 90 s.
Extension was at 72°C for 10 min. Southern analysis was performed on the
RT-PCR products with a probe corresponding to HSV-1 nucleotides 118811 to
118840 (LAT nucleotides 10 to 39; see Fig. 1E, probe e).
5 RACE. Poly(A) RNA was isolated from PC-12 cells 6 h after infection at
an MOI of 5 with a poly(dT) column. 5 rapid amplification of cDNA ends
(RACE) was done according to the protocol suggested by the manufacturer
(Invitrogen Life Technologies).
DNA sequencing. Sequencing of cloned DNA was done by standard dideoxy
sequencing.
Expression of AL protein in Escherichia coli. The AL open reading frame (AL
ORF) from the ATG codon to the last amino acid before the stop codon was
amplified from a cloned full-length RT-PCR product by PCR and fused to a His
tag-containing plasmid (Xpress system protein expression pTrcHis; Invitrogen
Life Technologies) and expressed in E. coli according to the manufacturer’s
protocol.
Anti-AL ORF peptide antibodies. Two peptides, one representing the putative
5 end of the AL protein (peptide 1, GRARKVFRTTRDRHGC) and one
representing the putative 3 end of the AL protein (peptide 2, KAEMTQQKQA
TAPRGC), were synthesized, and antibody was raised commercially in rabbits
(BioSource International, Camarillo, Calif.). The E. coli-expressed AL ORF was
recognized by both peptide antibodies on Western blots (data not shown), sug-
gesting that these antibodies would be capable of detecting an AL protein
produced by HSV-1. In some experiments, numerous AL-related bands were
detected in a laddering pattern (data not shown), suggesting that the E. coli-
expressed AL protein binds tightly to itself or other proteins.
Western blots. The E. coli-expressed AL-His tag fusion protein was either used
as a crude total cell extract or partially purified with a His-Bind Quick Column
(Novagen; catalogue no. 70159-4) according to the manufacturer’s directions.
The total extract or partially purified protein was run on standard 15% Tricine
gels with a wide sample well and transferred to a polyvinylidene difluoride
(PVDF) membrane. The membrane was cut into strips, and individual strips
were incubated with serum obtained from rabbits on day 57 p.i. The antibody
bound to the blots was visualized by chemiluminescence with secondary antibody
conjugated to horseradish peroxidase.
RESULTS
Detection of AL-RNA in tissue culture. For ease of under-
standing the results presented below, a schematic representa-
tion of the relative location of the AL gene, the RNA, and the
putative ORF is shown in Fig. 1. Figure 1A shows a schematic
presentation of the HSV-1 genome. The terminal and internal
inverted long repeats are expanded to show the LAT region in
8004 PERNG ET AL. J. VIROL.
 at UNIV O
F NEBRASKA-LINCO
LN on Septem
ber 19, 2007 
jvi.asm.org
D
ow
nloaded from
 
more detail (Fig. 1B). The primary 8.3-kb LAT transcript is
indicated by the large arrow. The stable 2-kb LAT (an intron)
is indicated by the solid rectangle. The relative locations of the
ICP0 and ICP34.5 mRNAs are shown for reference. The re-
gion near the 5 end of LAT is expanded to show details of the
LAT (Fig. 1C) and AL (Fig. 1D) regions. These two panels are
shown at the same scale and are aligned vertically. The AL-
RNA (Fig. 1D) is antisense to the LAT RNA (Fig. 1C). In
panels C and D, the numbers in parentheses represent nucle-
otide positions relative to the start of LAT transcription while
numbers not in parentheses represent nucleotide positions rel-
ative to the start of AL transcription. The locations of primers
and probes used in this report are shown relative to AL and
LAT in Fig. 1E.
Sequence analysis revealed a potential small ORF down-
stream of ICP0 in HSV-1 strains 17syn and McKrae, the only
strains for which this sequence is available. This ORF (Fig. 1D,
AL ORF) overlaps part of the LAT promoter and part of the
LAT region that is required for spontaneous reactivation (the
first 1.5 kb of the primary LAT transcript). Interestingly, the
transcript that would encode this novel ORF would be ex-
pressed antisense to LAT and would not be contained within
the ICP0 mRNA. To look for a potential RNA near the 5 end
of LAT that might encode this ORF, RS, CV-1, and PC-12
cells were infected with wild-type HSV-1 strain McKrae and
Northern blot analyses were performed. Probes specific for the
detection of anti-LAT transcripts in the immediate vicinity of
the LAT promoter and the start of LAT transcription were
FIG. 1. Relative location of the AL gene. (A) Schematic representation of the wild-type HSV-1 genome. TRL and IRL indicate the terminal
and inverted long repeats, respectively. IRS and TRS indicate the inverted and terminal short repeats, respectively. UL and US indicate the unique
long and unique short regions, respectively. The TRL and IRL are expanded, and the TRL is flipped left to right as indicated by the dashed lines,
so that both repeats can be represented together in the subsequent panels. (B) Blowup of the long repeats. The primary LAT transcript is indicated
by the large arrow. The solid rectangle represents the very stable 2-kb LAT intron. The LAT TATA box is indicated by TATA. The start of LAT
transcription is indicated by the arrow at 1 (genomic nucleotide 118801). Several restriction enzyme sites and the relative locations of the ICP0
and ICP34.5 transcripts are shown for reference. (C) Blowup of the 5 LAT region. The LAT promoter (open rectangle), the start of LAT
transcription (arrow, 1), a putative secondary LAT promoter (LAP2), and the beginning of the stable 2-kb LAT are indicated. Nucleotide
positions relative to the start of LAT transcription are shown in parentheses. (D) AL gene. The DNA strand opposite that of LAT in panel C is
shown. The numbers in parentheses indicate nucleotide positions relative to the start of LAT transcription on the other strand. The remaining
numbers indicate nucleotide positions relative to the start of AL transcription. The ORF encoding a putative AL protein is shown as an open
rectangle. The AL promoter is located somewhere between the large parentheses in the same region as LAP2. (E) Relative positions of
oligonucleotide primers (a to d) and probes (e) used in this report. a, 118661 to 118690; b, 118681 to 118710; c, 118841 to 118870; d, 118881 to
118910; e, 118811 to 118840
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used to detect this putative transcript. No such RNA was
reproducibly detected on Northern blots in any of these cells
(data not shown).
To look for a low-abundance transcript in this region, oligo-
nucleotide primers corresponding to LAT nucleotides 140 to
110 and109 to80 (genomic nucleotides 118661 to 118690
and 118910 to 118881, respectively) (primers a and d in Fig.
1E) were used for RT-PCR. Primer a was also used for first-
strand synthesis. Thus, the RT-PCR would produce a product
only from RNA that was antisense to LAT. PC-12 cells were
infected at an MOI of 5 with wild-type strain McKrae, and total
RNA was isolated 6 h p.i. An RT-PCR product of the size
predicted from the genomic sequence and that hybridized to
an internal probe corresponding to LAT nucleotides 80 to 39
(genomic nucleotides 118811 to 118840; probe e in Fig. 1E),
was readily detected (Fig. 2, lane 2). The expected size of the
RT-PCR product is shown in lane 8, which shows the PCR
product generated with wild-type McKrae genomic DNA with
the same primers. As expected, no RT-PCR product was de-
tected with RNA from uninfected PC-12 cells (lane 5) or when
reverse transcriptase was left out of the reaction mixture (lanes
1, 6, and 7). In addition, no RT-PCR product was detected in
PC-12 cells infected with the LAT virus dLAT2903 (20) (lane
4). This was expected, since the deletion in this mutant (LAT
nucleotides 161 to 1667) encompasses all of the RT-PCR
primers. This acts as a further control to confirm that the
RT-PCR product originated from the expected location. Also
as expected, an RT-PCR product indistinguishable from that
of wild-type-infected PC-12 cells was seen in PC-12 cells in-
fected with marker-rescued dLAT2903R (lane 3). These re-
sults revealed the presence of an RNA antisense to and over-
lapping the 5 end of LAT (AL-RNA).
Mapping the 5 end of AL-RNA. The 5 end of the AL-RNA
was determined by 5 RACE as described in Materials and
Methods, with an internal primer corresponding to HSV-1
genomic nucleotides 118841 to 118870 (Fig. 1E, primer c).
Briefly, PC-12 cells were infected with wild-type McKrae virus
at an MOI of 5. Total RNA was isolated 6 h p.i., and poly(A)
RNA was isolated with a poly(dT) column. 5 RACE mapped
the 5 end of the AL-RNA to nucleotide 118959 of the HSV-1
genome. This corresponds to LAT nucleotide158, but on the
other DNA strand (Fig. 1C).
Mapping the 3 end of AL-RNA. The 3 end of the AL-RNA
was mapped by poly(A) selection and RT-PCR. Briefly, RT-
PCR was performed on poly(A) RNA isolated from PC-12
cells infected with wild-type McKrae virus as described above.
Oligo(dT) was used as the first primer, and a synthetic oligo-
nucleotide corresponding to LAT nucleotides 120 to 91
(genomic nucleotides 118710 to 118681; primer b, Fig. 1E) was
used as the second primer. The resulting RT-PCR product was
cloned and sequenced. Reading from the 5 toward the 3 end
of the AL-RNA, the sequence was identical to that of the
genomic sequence in this region up to genomic nucleotide
118603 (Fig. 3). This corresponds to the nucleotide comple-
mentary to LAT nucleotide 198. After this nucleotide, the
sequence of the RT-PCR product diverged from the genomic
sequence. The divergent sequence corresponded to a 22-nu-
cleotide AU-rich region containing a consensus poly(A) at-
tachment signal (AAUAAA) (40) followed by a 24-nucleotide-
long poly(A) stretch.
The 22-nucleotide poly(A) attachment signal found in the
AL-RNA was not present at this location in the McKrae ge-
nome (Fig. 3). However, this sequence was found on the other
DNA strand at a location corresponding to AL nucleotides 227
to 248 (LAT nucleotides 91 to 70). In 17syn, the only
HSV-1 strain that has been completely sequenced (17, 18, 26),
FIG. 2. Detection of AL-RNA by RT-PCR. PC-12 cells were in-
fected at an MOI of 5. Total RNA was isolated 6 h p.i., and RT-PCR
was performed as described in Materials and Methods. Lanes: 1, no
RT, wild-type McKrae virus-infected PC-12 cells; 2, wild-type McKrae
virus; 3, dLAT2903R; 4, dLAT2903; 5, uninfected PC-12; 6, no RT,
dLAT2903; 7, no RT, uninfected PC-12; 8, marker, PCR of wild-type
McKrae viral DNA.
FIG. 3. Mapping the 3 end of the AL-RNA. RT-PCR was performed on poly(A) RNA isolated from PC-12 cells infected with wild-type
McKrae virus, and the RT-PCR product was cloned and sequenced as described in Materials and Methods. The resulting sequence is labeled RNA.
The “genome” sequence is from the same HSV-1 strain (McKrae). The asterisks in the “genome” sequence indicate identity to the RNA sequence.
This identity ends after genomic nucleotide 118603. The positions of the 5 primer and the 3 oligo(dT) primer are shown.
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this 22-nucleotide sequence is present at the same location as
in McKrae and was not found anywhere else in the viral ge-
nome. It is unclear how these 22 nucleotides were incorporated
into the AL-RNA. We sequenced three independently gener-
ated and cloned AL RT-PCR products with identical results.
Thus, it is extremely unlikely that the 22-nucleotide poly(A)
attachment sequence was due to an artifact. Regardless of
these 22 nucleotides, the above sequence information mapped
the genomic location of the 3 end of the AL-RNA to genomic
nucleotide 118603.
Potential location of the AL promoter. There is no TATA
box located near the 5 end of the AL-RNA. However, the
region of LAT corresponding to the general region in which
the AL promoter would be expected to be located (Fig. 1D)
has been reported to act as a promoter for the stable 2-kb LAT
intron (13) (Fig. 1C) which begins at LAT nucleotide 661. This
putative secondary LAT promoter has been termed LAP2 (7,
13). The LAP2 promoter contains several bidirectional ele-
ments, such as Sp1 (12), and can enhance transcription in both
orientations (2). Thus, it is possible that LAP2 acts as the AL
gene promoter.
Kinetics of AL-RNA expression in tissue culture. PC-12 cells
were infected as described above. RNA was extracted at dif-
ferent times p.i., and the presence or absence of AL-RNA was
determined by RT-PCR as described in Materials and Meth-
ods with poly(dT) for first-strand synthesis and AL-specific
primers (a and d; Fig. 1E) for the PCR. AL-RNA was detected
as early as 4 h p.i., peaked at 6 h p.i., and then declined (Fig.
4). These kinetics were similar to those of the immediate-early
gene ICP0 mRNA (data not shown). The kinetics of AL-RNA
expression also appeared to be complementary to the kinetics
of the expression of LAT RNA, which first became apparent at
6 to 8 h p.i. (data not shown). This is consistent with the
possibility of some form of antisense regulation between these
two genes.
Sequence analysis of the AL ORF. The entire sequence of
the AL-RNA was determined by cloning and sequencing of
overlapping RT-PCR products made against AL-RNA tran-
scribed in wild-type McKrae virus-infected PC-12 cells. Except
for the poly(A) addition sequence discussed above, the AL-
RNA sequence was identical to that of the genomic sequence
FIG. 4. Kinetics of AL-RNA expression. PC-12 cells were infected
at an MOI of 5 with wild-type McKrae virus. Total RNA was isolated
at various times p.i., and RT-PCR was performed as described in
Materials and Methods. Lanes: 1, positive control (PCR of plasmid AL
DNA); 2, uninfected; 3, 2 h p.i.; 4, 4 h p.i.; 5, 6 h p.i.; 6, 8 h p.i.; 7, 10 h
p.i.; 8, 12 h p.i.; 9, 14 h p.i.; 10, no RT, 8 h p.i.
FIG. 5. Complete sequence of AL-RNA. The sequence was determined as described in the text. AL-RNA indicates the DNA sequence
corresponding to the AL-RNA sequence. The genomic sequence is from McKrae (the same HSV-1 strain as the RNA). The AL ORF begins with
a methionine (M) at AL nucleotide 61 and ends with a TAG at AL nucleotide 229. The boxed C at genomic nucleotide location 118769 indicates
the only nucleotide difference in AL between McKrae and HSV-1 strain 17syn, which contains a G at this location. The boxed Q indicates that
the nucleotide change from C to G changed the predicted amino acid from Q in McKrae to E in 17syn.
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(Fig. 5). Thus, there did not appear to be any obvious splicing
of the AL-RNA. Sequence analysis indicated a potential ORF
beginning with an ATG at nucleotide 61 of the AL-RNA (with
the A corresponding to a T at LAT nucleotide 97). There is
an in-frame TAG stop codon at AL-RNA nucleotide 229 (with
the T corresponding to an A at LAT nucleotide 71). The
total length of the predicted AL ORF is therefore 171 nucle-
otides (including the stop codon). The AL ORF is capable of
coding for a protein of 56 amino acids (168 nucleotides without
the stop codon) (Fig. 5). Based on the published genomic
sequence for 17syn in this region (17, 26), McKrae and
17syn both contain this AL ORF, with only a single nucleo-
tide difference. In the McKrae AL, nucleotide 190 of the
mRNA (nucleotide 129 of the ORF) is C (Fig. 5, boxed nu-
cleotide), while in the 17syn sequence this nucleotide is G.
This changes amino acid 43 from glutamine (Fig. 5, boxed
amino acid Q) in McKrae to glutamic acid in 17syn. The high
level of conservation (98% identity) of the putative AL ORF
in these two HSV-1 strains supports the likelihood that this is
a functional ORF.
The AL ORF is expressed in rabbits infected with wild-type
HSV-1. As described in Materials and Methods, antibody was
raised against two synthetic AL peptides and against the full-
length AL ORF fused to a His tag recombinantly expressed in
E. coli. These three anti-AL antibodies were used for detection
of the putative AL protein in extracts of tissue culture cells
infected with wild-type HSV-1. Although AL protein-specific
bands appeared to be detected on Western blots, all of the
antibodies appeared to react with numerous additional bands.
The background was thus too high to obtain conclusive results
(data not shown). We therefore took an alternative approach.
We looked for the presence of anti-AL antibody in the sera of
rabbits infected with wild-type virus. Sera from rabbits infected
with dLAT2903 (LAT/AL) were used as controls.
Rabbits were infected in both eyes with 2  105 PFU of
wild-type McKrae or dLAT2903 virus per eye, and serum was
collected from individual rabbits 57 days p.i., a time at which
latency had been well established. Total cell extract from E.
coli expressing the AL-His tag fusion protein was run on a
Tricine gel in a large loading well. The protein was transferred
by blotting to PVDF membrane. The membrane was then cut
into strips, and the different strips were reacted with different
sera (Fig. 6A). Individual sera from three different wild-type-
infected rabbits (lanes 1, 2, and 3) recognized a band corre-
sponding in mobility to the AL band recognized by anti-AL
ORF peptide antibody (lane M, arrow). In contrast, none of
the dLAT2903-infected rabbit sera (lanes 4, 5, and 6) or un-
infected rabbit sera (lane U) appeared to recognize this band.
In preliminary experiments, we found that antibodies raised
against two different synthetic AL peptides reacted with the
same band recognized by the anti-His tag antibody and that
this band had an apparent molecular weight consistent with
that expected for the AL-His tag protein (data not shown).
To reduce some of the background bands seen in Fig. 6A,
AL-His tag fusion protein was partially purified from E. coli
extracts with a His tag binding column as described in Mate-
rials and Methods. Western blots were then made as described
above with wild-type serum 3 and dLAT2903 serum 4 (Fig.
6B). The background was greatly reduced, making it easier to
visualize anti-AL antibody in the wild-type sera.
The sera used in Fig. 6A, along with three additional sera
from wild-type-infected rabbits and three additional sera from
dLAT2903-infected rabbits, were further examined for the
presence of AL antibodies by enzyme-linked immunosorbent
assays (ELISAs). ELISA plates were coated with AL synthetic
peptide 1 or 2. Sera from four of six wild-type-infected rabbits
contained small but significant amounts of immunoglobulin G
to either peptide 1 or 2 or both, based on their positive ELISA
titers against these peptides. In contrast none of the sera from
dLAT2903-infected rabbits produced an ELISA reading above
background (P  0.03, single-sided Fisher exact test).
Thus, the AL protein appeared to be expressed following
ocular infection of rabbits. The minimal reactivity of the wild-
type-infected rabbit serum with the AL-His tag fusion protein
and the AL synthetic peptides suggests either that the AL
protein is not very immunogenic and/or that only small
amounts of AL protein were produced.
DISCUSSION
We report here on the discovery and initial characterization
of a novel HSV-1 gene that is antisense to LAT and overlaps
198 nucleotides of the LAT promoter and 158 nucleotides of
the 5 end of the primary 8.3-kb LAT transcript. We have
designated this gene AL, for anti-LAT sense. Interestingly, we
FIG. 6. Detection of E. coli-expressed AL protein by sera from
infected rabbits. (A) Total extract from E. coli expressing the AL-His
tag fusion protein was run on a 15% Tricine gel with a single large
loading well and transferred to a PVDF membrane. The membrane
was cut into strips, and each strip was separately reacted with the
indicated antibody. The strips were then reacted with horseradish
peroxidase-conjugated secondary antibody for chemifluorescence. The
arrow indicates the location of the E. coli-expressed AL-His tag fusion
protein. Lane M, anti-His tag antibody as marker. Lane U, serum from
an uninfected rabbit. Lanes 1 to 3, sera from three different rabbits
infected with wild-type virus. Lanes 4 to 6, sera from three different
rabbits infected with dLAT2903 (a LAT and AL-null mutant). (B) The
E. coli-expressed AL-His tag protein was partially purified as described
in Materials and Methods and processed as for panel A. Lane M,
anti-His tag antibody as marker. Lane U, serum from an uninfected
rabbit different from the serum in panel A. Lanes 3 and 4, the same
rabbit sera as in lanes 3 and 4 in panel A. wt, wild type.
8008 PERNG ET AL. J. VIROL.
 at UNIV O
F NEBRASKA-LINCO
LN on Septem
ber 19, 2007 
jvi.asm.org
D
ow
nloaded from
 
were unable to detect an AL transcript by standard Northern
blot analysis (data not shown). However, we were able to
detect the AL transcript by RT-PCR. This is similar to the
UL43 gene of HSV-1, which also could not be detected by
Northern blotting but was detected by RT-PCR (6). As sug-
gested elsewhere for UL43 RNA (6), the difficulty in detecting
AL RNA may have been due to low-level transcription, high
turnover rate, or the fact that AL overlaps LAT in an antisense
direction. Double-stranded RNA resulting from complemen-
tary AL and LAT RNA could result in rapid degradation by
cellular enzymes (37).
The amino acid sequence of the putative AL protein is
highly conserved in HSV-1 strains McKrae and 17syn (98%
identical). This level of amino acid sequence conservation is
similar to that seen with other HSV-1 proteins (10). However,
it is in sharp contrast to the much lower amino acid sequence
conservation of 10 to 80% in eight potential ORFs within the
first 1.5 kb of LAT (located on the other DNA strand opposite
AL) (10). Based on the low conservation, it was concluded that
none of these potential LAT ORFs encode a protein involved
in the HSV-1 reactivation phenotype. In contrast, the high
conservation of the putative AL protein amino acid sequence
suggests that there is strong selective pressure to maintain the
amino acid sequence. This suggests that AL encodes a protein.
We found that rabbits infected with wild-type HSV-1 by the
ocular route developed antibodies to the AL protein. This is
strong evidence that the AL protein was produced during acute
and/or latent infection in rabbits. Combined with the high
sequence conservation, it is therefore likely that AL is ex-
pressed by the virus in certain cell types and may play a role in
the pathogenic potential of HSV-1. The apparently low level of
AL antibody and our inability to detect AL protein above the
background in infected cells in tissue culture suggested that AL
is a low-abundance protein and/or it is produced only in certain
cell types or at certain times, such as during latency.
The relative locations of the LAT and AL genes as pre-
sented in this study suggest the possibility of antisense regula-
tion of LAT by AL or vice versa. This may be important in the
latency-reactivation cycle. We found an apparent discordance
between transcription of AL and LAT in tissue culture. AL
transcription is greatest prior to the time that LAT expression
becomes readily apparent. Transcription of AL decreases after
6 h p.i., the time that LAT expression increases dramatically.
This is consistent with the possibility of some form of antisense
regulation between AL and LAT. It has been reported else-
where that dexamethasone-induced reactivation of bovine her-
pesvirus 1 results in transient reduction of LAT expression
(27). This decrease in LAT may be a key factor in reactivation.
It is possible that a reactivation stimulus either directly or
indirectly up regulates AL transcription and that this in turn
down regulates LAT, which then leads to reactivation.
We (21, 24) and others (41) have suggested elsewhere that
LAT, or the region of the HSV-1 genome near the start of the
primary LAT transcript, may be involved in viral virulence.
Zhu et al. (41) described a 0.7-kb RNA that overlaps the LAT
promoter, is transcribed in the LAT direction, and terminates
just prior to the start of LAT. They also showed that a mutant
with a deletion in this 0.7-kb region has altered virulence in
mice. Interestingly, this mutant also deletes a portion of the
AL gene. The altered virulence of this mutant may therefore
be due to partial deletion of the 0.7-kb LAT sense RNA or
partial deletion of the AL gene. We have also reported alter-
ations in viral virulence in three mutants with deletions within
the 5 end of the primary 8.3-kb LAT transcript (21, 24).
dLAT1.5 has a deletion of LAT nucleotides 76 to 1499 (cor-
responding to AL nucleotides 82 to 1342). dLAT371 has a
deletion of LAT nucleotides 76 to 447 (corresponding to AL
nucleotides 82 to 289). Both of these mutants express the
remainder of LAT. In contrast, LAT2.9A, which contains the
same deletion as dLAT371, also does not express LAT nucle-
otides 1500 to 8324 (the end of LAT). These deletions do not
alter the structure of the genomic region encoding the 0.7-kb
LAT sense RNA. However, they may impact expression of the
0.7-kb RNA, since expression of this RNA was abolished in an
HSV-1 strain 17synmutant similar to dLAT371 (41). Thus, it
remains possible that the altered virulence phenotypes of all
four of these mutants (one directly affecting the 0.7-kb tran-
script and AL and three directly affecting LAT and AL and
probably indirectly affecting the 0.7-kb RNA) may be due to
AL.
LAT-null mutants that also delete AL or significantly disrupt
the AL ORF do not appear to have altered virulence (3, 4, 14,
20, 30). It is therefore possible that LAT and AL have oppos-
ing and balanced functions with respect to viral virulence.
Blocking expression of both genes simultaneously would then
have no obvious virulence phenotype. In contrast, three mu-
tants with deletions that remove the 5 end of AL (AL-null
mutants) but do not disrupt the LAT promoter (and hence
allow the mutants to continue to express the region of LAT
outside of the deletion) do have altered virulence (21, 24). It is
possible that this is the result of altering the balance between
an AL function and a LAT function. In addition, the virulence
phenotypes of these three mutants differ from each other and
also differ between rabbits and mice. Since each of these mu-
tants expresses different LAT transcripts, it is also possible that
there is an intricate balance between one or more AL functions
and functions due to different regions of LAT.
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